Skip to Content

The CRISPR Competitor That Wasn’t

August 3, 2017

At this point, CRISPR is essentially synonymous with the process of gene-editing. But many researchers are trying to find alternatives, and in May 2016 Chinese researchers published a study which suggested that an enzyme called NgAgo could be used to slice and dice DNA instead of the cas9 enzyme used by CRISPR. (For a run down on how the hell CRISPR works, check out our two-minute explainer.) At the time, the researchers even said that NgAgo might end up more versatile than its infamous competitor. But things haven’t played out well for the team from Hebei University of Science and Technology in Shijiazhuang, China. Nature reports that other laboratories have tried to replicate the NgAgo approach and failed, forcing the researchers to retract their original paper. CRISPR can rest easy.

Deep Dive


Embracing CX in the metaverse

More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.

Identity protection is key to metaverse innovation

As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.

The modern enterprise imaging and data value chain

For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.

Scientists have created synthetic mouse embryos with developed brains

The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.